Literature DB >> 9705432

Molecular epidemiology of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae isolates in a district hospital in Taiwan.

P Y Liu1, J C Tung, S C Ke, S L Chen.   

Abstract

Thirty-one of 104 clinical isolates of Klebsiella pneumoniae collected over a period of 8 months were found to be putative extended-spectrum beta-lactamase (ESBL) producers. Isoelectric focusing and an iodine overlay agar method were used for preliminary identification of the ESBLs. They were further identified by DNA sequencing. Seventy-one percent of the isolates were found to produce SHV-5. The variation in the ESBL patterns of these isolates was slight, with only five patterns being identified. The strains were typed by pulsed-field gel electrophoresis (PFGE), and 16 different genotypes were identified. When the PFGE patterns were analyzed by the algorithmic clustering method called the unweighted-pair group method using arithmetic averages, five clusters were found. However, significant genetic variations were found among 11 isolates and between each cluster. A plasmid of 36 kb was found in all clinical isolates and in the transconjugants. Our results indicate that the increase in the number of ESBL-producing K. pneumoniae isolates in this hospital is due mainly to the dissemination of a resistance plasmid rather than to the clonal spread of a few epidemic strains.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9705432      PMCID: PMC105202     

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  25 in total

1.  Outbreak of ceftazidime resistance caused by extended-spectrum beta-lactamases at a Massachusetts chronic-care facility.

Authors:  L B Rice; S H Willey; G A Papanicolaou; A A Medeiros; G M Eliopoulos; R C Moellering; G A Jacoby
Journal:  Antimicrob Agents Chemother       Date:  1990-11       Impact factor: 5.191

2.  Evolution of plasmid-coded resistance to broad-spectrum cephalosporins.

Authors:  C Kliebe; B A Nies; J F Meyer; R M Tolxdorff-Neutzling; B Wiedemann
Journal:  Antimicrob Agents Chemother       Date:  1985-08       Impact factor: 5.191

3.  Dissemination of the novel plasmid-mediated beta-lactamase CTX-1, which confers resistance to broad-spectrum cephalosporins, and its inhibition by beta-lactamase inhibitors.

Authors:  M D Kitzis; D Billot-Klein; F W Goldstein; R Williamson; G Tran Van Nhieu; J Carlet; J F Acar; L Gutmann
Journal:  Antimicrob Agents Chemother       Date:  1988-01       Impact factor: 5.191

4.  The use of analytical isoelectric focusing for detection and identification of beta-lactamases.

Authors:  A Mathew; A M Harris; M J Marshall; G W Ross
Journal:  J Gen Microbiol       Date:  1975-05

Review 5.  Extended-spectrum beta-lactamases and other enzymes providing resistance to oxyimino-beta-lactams.

Authors:  G A Jacoby
Journal:  Infect Dis Clin North Am       Date:  1997-12       Impact factor: 5.982

6.  Concomitant dissemination of three extended-spectrum beta-lactamases among different Enterobacteriaceae isolated in a French hospital.

Authors:  C de Champs; D Sirot; C Chanal; M C Poupart; M P Dumas; J Sirot
Journal:  J Antimicrob Chemother       Date:  1991-04       Impact factor: 5.790

7.  Outbreak of infection in two UK hospitals caused by a strain of Klebsiella pneumoniae resistant to cefotaxime and ceftazidime.

Authors:  A P Johnson; M J Weinbren; B Ayling-Smith; S K Du Bois; S G Amyes; R C George
Journal:  J Hosp Infect       Date:  1992-02       Impact factor: 3.926

8.  Molecular epidemiology of TEM-3 (CTX-1) beta-lactamase.

Authors:  A Petit; G Gerbaud; D Sirot; P Courvalin; J Sirot
Journal:  Antimicrob Agents Chemother       Date:  1990-02       Impact factor: 5.191

9.  Resistance to cefotaxime and seven other beta-lactams in members of the family Enterobacteriaceae: a 3-year survey in France.

Authors:  D L Sirot; F W Goldstein; C J Soussy; A L Courtieu; M O Husson; J Lemozy; M Meyran; C Morel; R Perez; C Quentin-Noury
Journal:  Antimicrob Agents Chemother       Date:  1992-08       Impact factor: 5.191

10.  Outbreak of ceftazidime resistance due to a novel extended-spectrum beta-lactamase in isolates from cancer patients.

Authors:  L Naumovski; J P Quinn; D Miyashiro; M Patel; K Bush; S B Singer; D Graves; T Palzkill; A M Arvin
Journal:  Antimicrob Agents Chemother       Date:  1992-09       Impact factor: 5.191

View more
  20 in total

1.  Three cefotaximases, CTX-M-9, CTX-M-13, and CTX-M-14, among Enterobacteriaceae in the People's Republic of China.

Authors:  Aroonwadee Chanawong; Fatima Hannachi M'Zali; John Heritage; Jian-Hui Xiong; Peter Michael Hawkey
Journal:  Antimicrob Agents Chemother       Date:  2002-03       Impact factor: 5.191

2.  Dissemination of extended-spectrum beta-lactamase-producing Enterobacteriaceae in pediatric intensive care units.

Authors:  Tsu-Lan Wu; Ju-Hsin Chia; Lin-Hui Su; An-Jing Kuo; Chishih Chu; Cheng-Hsun Chiu
Journal:  J Clin Microbiol       Date:  2003-10       Impact factor: 5.948

3.  Detection of cefotaxime-resistant CTX-M-3 in clinical isolates of Serratia marcescens.

Authors:  Mei-Fen Tsou; Wen-Liang Yu; Siu Wan Hung; Chizh-Ju Chi; Ssu Ching Chen; Lii-Tzu Wu
Journal:  Folia Microbiol (Praha)       Date:  2004       Impact factor: 2.099

4.  Analysis of bla(SHV) codon 238 and 240 allele mixtures using Sybr green high-resolution melting analysis.

Authors:  Patiyan Andersson; Tegan Harris; Steven Y C Tong; Philip M Giffard
Journal:  Antimicrob Agents Chemother       Date:  2009-04-06       Impact factor: 5.191

5.  Characterization of extended-spectrum beta-lactamase (TEM-52)-producing strains of Salmonella enterica serovar typhimurium with diverse resistance phenotypes.

Authors:  H Vahaboglu; M Fuzi; S Cetin; S Gundes; E Ujhelyi; F Coskunkan; O Tansel
Journal:  J Clin Microbiol       Date:  2001-02       Impact factor: 5.948

6.  Dissemination of CTX-M-3 and CMY-2 beta-lactamases among clinical isolates of Escherichia coli in southern Taiwan.

Authors:  J J Yan; W C Ko; S H Tsai; H M Wu; Y T Jin; J J Wu
Journal:  J Clin Microbiol       Date:  2000-12       Impact factor: 5.948

7.  Development of a multiplex PCR and SHV melting-curve mutation detection system for detection of some SHV and CTX-M beta-lactamases of Escherichia coli, Klebsiella pneumoniae, and Enterobacter cloacae in Taiwan.

Authors:  Ju-Hsin Chia; Chishih Chu; Lin-Hui Su; Cheng-Hsun Chiu; An-Jing Kuo; Chien-Feng Sun; Tsu-Lan Wu
Journal:  J Clin Microbiol       Date:  2005-09       Impact factor: 5.948

8.  Cytotoxic effects of Klebsiella oxytoca strains isolated from patients with antibiotic-associated hemorrhagic colitis or other diseases caused by infections and from healthy subjects.

Authors:  Martina M Joainig; Gregor Gorkiewicz; Eva Leitner; Paul Weberhofer; Ines Zollner-Schwetz; Irmgard Lippe; Gebhard Feierl; Robert Krause; Thomas Hinterleitner; Ellen L Zechner; Christoph Högenauer
Journal:  J Clin Microbiol       Date:  2010-01-06       Impact factor: 5.948

9.  Molecular epidemiology of Enterobacteriaceae isolates producing extended-spectrum beta-lactamases in a French hospital.

Authors:  Jean-Philippe Lavigne; Nicole Bouziges; Catherine Chanal; Aba Mahamat; Sylvie Michaux-Charachon; Albert Sotto
Journal:  J Clin Microbiol       Date:  2004-08       Impact factor: 5.948

10.  Cefepime MIC as a predictor of the extended-spectrum beta-lactamase type in Klebsiella pneumoniae, Taiwan.

Authors:  Wen Liang Yu; Michael A Pfaller; Patricia L Winokur; Ronald N Jones
Journal:  Emerg Infect Dis       Date:  2002-05       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.